Photodynamic Therapy with Verteporfin for Subfoveal Choroidal Neovascular Membranes in Highly Myopic Eyes after Laser In situ Keratomileusis

J. Fernando Arevalo, José Ma Ruiz-Moreno, Carlos F. Fernandez, Aristides J. Mendoza, Ernesto Ramirez, Javier A. Montero

Research output: Contribution to journalArticle

Abstract

The authors describe the management of subfoveal choroidal neovascular membranes in highly myopic eyes after laser in situ keratomileusis with photodynamic therapy. Five cases of choroidal neovascular membrane after laser in situ keratomileusis for the correction of myopia (mean, 13.3 diopters; range, -8.00 to -16.25 diopters) treated with single or multiple sessions of photodynamic therapy with verteporfin are presented. Two cases had improved visual acuity (2 to 5 lines) after photodynamic therapy, two cases remained the same, and one case lost 4 lines of visual acuity. Photodynamic therapy with verteporfin seems to increase the chance of stabilizing or improving vision in patients with subfoveal choroidal neovascular membrane after laser in situ keratomileusis in highly myopic eyes.

Original languageEnglish (US)
Pages (from-to)58-62
Number of pages5
JournalOphthalmic Surgery Lasers and Imaging
Volume35
Issue number1
DOIs
StatePublished - Jan 1 2004

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Fingerprint Dive into the research topics of 'Photodynamic Therapy with Verteporfin for Subfoveal Choroidal Neovascular Membranes in Highly Myopic Eyes after Laser In situ Keratomileusis'. Together they form a unique fingerprint.

  • Cite this